What’s New at APS BioGroup

January 21, 2014

APS BioGroup Announces Completion of Facility Expansion and Enhanced Capabilities

APS BioGroup Announces Completion of Facility Expansion and Enhanced Capabilities

Bob Davies (President and CEO) said: "With completion of this expansion our capabilities to grow and serve our customers are significantly enhanced. Our colostrum plant processing capacity has been increased by 50%, our contract manufacturing capacity has been increased by 75% and we have hired five additional college graduate scientists in our laboratory to increase our in-house testing and compliance capabilities."